UNRESECTABLE COLORECTAL ADENOCARCINOMA

Clinical trials for UNRESECTABLE COLORECTAL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE COLORECTAL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Scientists test new pill to boost power of standard colon cancer treatment

Disease control Recruiting now

This early-stage trial is testing the safety and best dose of a new oral drug, CA-4948, when added to a standard chemotherapy regimen for people with advanced colorectal cancer that has spread. The main goal is to see if the combination is safe and tolerable for patients. Researc…

Matched conditions: UNRESECTABLE COLORECTAL ADENOCARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 11, 2026 14:54 UTC

UNRESECTABLE COLORECTAL ADENOCARCINOMA

Get alerted when new UNRESECTABLE COLORECTAL ADENOCARCINOMA trials appear

Scientists test new pill to boost power of standard colon cancer treatment